A large study on the impact of long COVID found increased rates of health system use 2 months after infection with SARS-CoV-2, which has implications for health care delivery in the future. The study, which included more ...
Oct 17, 2022
0
50
Researchers have developed easy-to-use online prediction tools that provide personalized risk estimates for patients undergoing hysterectomy for benign disease. The study describing the models is published in CMAJ (Canadian ...
Oct 3, 2022
0
28
Patients with chronic heart failure who received collaborative, home-based palliative care were less likely to die in hospital and more likely to die at home than people who received usual care, according to new research ...
Sep 26, 2022
0
19
Natalie Stake-Doucet is haunted by deaths she witnessed working as a long-term care nurse in Montreal during the early waves of the pandemic.
Sep 23, 2022
0
4
Canada needs a better infectious disease surveillance system to detect emerging respiratory pathogens that includes waste-water testing, population-based testing and genomics, according to an analysis published in Canadian ...
Sep 19, 2022
0
40
For people at high risk of overdose enrolled in a safer opioid supply (SOS) program, there was a rapid decrease in emergency department visits and hospitalizations soon after initiation, according to new research published ...
Sep 19, 2022
0
12
Emergency departments across Canada that have usually been open 24/7 are increasingly closing overnight and on weekends as health systems grapple with escalating nursing shortages.
Aug 12, 2022
0
3
Despite prioritizing Indigenous populations for SARS-CoV-2 vaccinations, vaccine uptake was low among First Nations, Inuit and Métis Peoples in Toronto and London, Ontario, according to new research published in CMAJ (Canadian ...
Aug 2, 2022
0
12
Depression in pregnant and postpartum people is a serious problem. Rather than using a screening tool with a cut-off score to detect depression in every pregnant and postpartum patient, clinicians should ask patients about ...
Jul 25, 2022
0
2
The antiviral drugs molnupiravir and nirmatrelvir–ritonavir (Paxlovid), when used to treat nonsevere COVID-19, most likely reduce the risk of subsequent progression to hospitalization and death, according to new research ...
Jul 25, 2022
0
7
